サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1370585

ニュートリゲノミクス市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Nutrigenomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 142 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ニュートリゲノミクス市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年10月15日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

市場概要：

世界のニュートリゲノミクス市場規模は、2022年に10億8,300万米ドルに達しました。今後、IMARC Groupは、市場は2023年から2028年の間に12%の成長率（CAGR）を示し、2028年までに22億7,800万米ドルに達すると予測しています。

ニュートリゲノミクスは栄養ゲノミクスとも呼ばれ、栄養、健康、ヒトゲノムの関係を分析する医学のサブセットです。遺伝子と食生活の相関関係を理解し、それらが人の健康や、がん、心血管疾患（CVDs）、肥満などの病気の発症リスクに及ぼす影響を理解することに重点を置いています。ニュートリゲノミクスは、老化や疾病の素因を検出し、遺伝子型に応じてパーソナライズされた食事や栄養計画を立てるのに役立ちます。また、大栄養素や微量栄養素の毒性や安全性プロファイルを理解し、食事に関連する疾患を予防するのにも役立ちます。このほか、ニュートリゲノミクス検査は一般的に血液、頬ぬぐい液、唾液のサンプルを採取して行われます。

ニュートリゲノミクス市場の動向：

世界中で肥満の有病率が上昇しており、市場の見通しは明るいです。ニュートリゲノミクスは、個々の遺伝子レベルを理解するのに役立ち、それに基づいて適切な栄養食が与えられ、さらに肥満の減少をもたらします。さらに、健康とフィットネスに対する消費者の傾向の高まりと、特にアスリートやフィットネス愛好家の間で、パーソナライズされた栄養製品に対する需要の高まりが、市場の成長を後押ししています。これとは別に、主な企業は研究開発（R&D）活動に積極的に投資し、ヒト遺伝学を発見の基礎として革新的な医療や潜在的な治療法を導入しています。また、弱った免疫システムを強化し、コレステロール化合物の摂取を減らすなど、特定の遺伝子プロファイルに適合するオーダーメイド食品の開発にも注力しており、これが市場の成長を促進しています。さらに、ビタミンDやK、葉酸、鉄貧血、低カルシウム血症、骨軟化症、乾皮症、壊血病、ペラグラ、くる病などの栄養欠乏症が増加していることも成長を促す要因となっています。これに加えて、大衆の健康意識の高まり、心臓病、糖尿病、その他の慢性疾患のリスクを軽減するための栄養価の高い食品の消費の増加、ニュートリゲノミクス検査の利点に関する意識の高まりが、市場の成長を促進すると予想されます。

本レポートで扱う主な質問

  • 世界のニュートリゲノミクス市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界のニュートリゲノミクス市場に与えた影響は？
  • 主要な地域市場は？
  • 製品別の市場内訳は？
  • サンプルタイプ別の市場内訳は？
  • 用途別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界のニュートリゲノミクス市場の構造と主要プレイヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のニュートリゲノミクス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 試薬・キット
    • 市場動向
    • 市場予測
  • サービス
    • 市場動向
    • 市場予測

第7章 市場内訳：サンプルタイプ別

  • 唾液
    • 市場動向
    • 市場予測
  • 綿棒
    • 市場動向
    • 市場予測
  • 血液
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • 心血管疾患
    • 市場動向
    • 市場予測
  • 肥満症
    • 市場動向
    • 市場予測
  • がん調査
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 栄養士
    • 市場動向
    • 市場予測
  • スポーツクリニック
    • 市場動向
    • 市場予測
  • 企業向けプログラム
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • BASF SE
    • Cell-Logic
    • Cura Integrative Medicine
    • Danone S.A
    • Fagron
    • Genova Diagnostics
    • Holistic Health International
    • Koninklijke DSM N.V.
    • Metagenics Inc.
    • Nutrigenomix Inc.
    • Xcode Life
図表

List of Figures

  • Figure 1: Global: Nutrigenomics Market: Major Drivers and Challenges
  • Figure 2: Global: Nutrigenomics Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Nutrigenomics Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Nutrigenomics Market: Breakup by Sample Type (in %), 2022
  • Figure 6: Global: Nutrigenomics Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Nutrigenomics Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Nutrigenomics Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Nutrigenomics (Reagents and Kits) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Nutrigenomics (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Nutrigenomics (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Nutrigenomics (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Nutrigenomics (Saliva) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Nutrigenomics (Saliva) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Nutrigenomics (Buccal Swab) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Nutrigenomics (Buccal Swab) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Nutrigenomics (Blood) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Nutrigenomics (Blood) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Nutrigenomics (Other Sample Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Nutrigenomics (Other Sample Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Nutrigenomics (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Nutrigenomics (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Nutrigenomics (Obesity) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Nutrigenomics (Obesity) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Nutrigenomics (Cancer Research) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Nutrigenomics (Cancer Research) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Nutrigenomics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Nutrigenomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Nutrigenomics (Dieticians) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Nutrigenomics (Dieticians) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Nutrigenomics (Sport Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Nutrigenomics (Sport Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Nutrigenomics (Corporate Programs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Nutrigenomics (Corporate Programs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: North America: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: North America: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: United States: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: United States: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Canada: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Canada: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Asia-Pacific: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Asia-Pacific: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: China: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: China: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Japan: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Japan: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: India: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: India: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: South Korea: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: South Korea: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Australia: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Australia: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Indonesia: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Indonesia: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Others: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Others: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Europe: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Europe: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Germany: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Germany: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: France: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: France: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: United Kingdom: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: United Kingdom: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Italy: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Italy: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Spain: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Spain: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Russia: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Russia: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Others: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Others: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Latin America: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Latin America: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Brazil: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Brazil: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Mexico: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Mexico: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Others: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Others: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Middle East and Africa: Nutrigenomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Middle East and Africa: Nutrigenomics Market: Breakup by Country (in %), 2022
  • Figure 83: Middle East and Africa: Nutrigenomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Global: Nutrigenomics Industry: SWOT Analysis
  • Figure 85: Global: Nutrigenomics Industry: Value Chain Analysis
  • Figure 86: Global: Nutrigenomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nutrigenomics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Nutrigenomics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Nutrigenomics Market Forecast: Breakup by Sample Type (in Million US$), 2023-2028
  • Table 4: Global: Nutrigenomics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Nutrigenomics Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Nutrigenomics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Nutrigenomics Market: Competitive Structure
  • Table 8: Global: Nutrigenomics Market: Key Players
目次
Product Code: SR112023A6568

Abstract

Market Overview:

The global nutrigenomics market size reached US$ 1,083 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,278 Million by 2028, exhibiting a growth rate (CAGR) of 12% during 2023-2028.

Nutrigenomics, also known as nutritional genomics, is a subset of medical science that analyzes the relationship between nutrition, health, and the human genome. It focuses on understanding the correlation between genes and diet and their effect on a person's health and the risk of developing diseases, such as cancer, cardiovascular diseases (CVDs), and obesity. Nutrigenomics helps detect factors of aging and disease predisposition and create personalized diet or nutrition plans depending on genotype. It also assists in understanding the toxicity and safety profile of macro- and micronutrients and preventing diet-associated diseases. Besides this, nutrigenomics testing is commonly done by taking samples of blood, buccal swabs, and saliva.

Nutrigenomics Market Trends:

The rising prevalence of obesity across the globe is creating a positive outlook for the market. Nutrigenomics helps understand the individual gene level, according to which a proper nutrition diet is given, further resulting in decreased obesity. Additionally, the growing consumer inclination toward health and fitness and the increasing demand for personalized nutrition products, especially among athletes and fitness enthusiasts, is favoring the market growth. Apart from this, key players are extensively investing in research and development (R&D) activities to introduce innovative medicine and potential cures using human genetics as a basis for discovery. They are also focusing on developing tailor-made food to match a particular gene profile, such as strengthening the weak immune system and decreasing the intake of cholesterol compounds, which, in turn, is facilitating the market growth. Moreover, the increasing incidences of nutritional deficiency disorders, such as lack of vitamins D and K, folate, iron anemia, hypocalcemia, osteomalacia, xerophthalmia, scurvy, pellagra, and rickets, are acting as another growth-inducing factor. Besides this, the rising health consciousness among the masses, increasing consumption of nutritious food to mitigate risks of heart diseases, diabetes, and other chronic diseases, and growing awareness about the benefits of nutrigenomic testing are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global nutrigenomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, sample type, application and end user.

Breakup by Product:

Reagents and Kits

Services

Breakup by Sample Type:

Saliva

Buccal Swab

Blood

Others

Breakup by Application:

Cardiovascular Diseases

Obesity

Cancer Research

Others

Breakup by End User:

Dieticians

Sport Clinics

Corporate Programs

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Cell-Logic, Cura Integrative Medicine, Danone S.A, Fagron, Genova Diagnostics, Holistic Health International, Koninklijke DSM N.V., Metagenics Inc., Nutrigenomix Inc. and Xcode Life.

Key Questions Answered in This Report:

  • How has the global nutrigenomics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global nutrigenomics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the sample type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global nutrigenomics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nutrigenomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Reagents and Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Sample Type

  • 7.1 Saliva
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Buccal Swab
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Blood
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Cardiovascular Diseases
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Obesity
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cancer Research
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Dieticians
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Sport Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Corporate Programs
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 BASF SE
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Cell-Logic
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Cura Integrative Medicine
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Danone S.A
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Fagron
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Genova Diagnostics
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Holistic Health International
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Koninklijke DSM N.V.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Metagenics Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Nutrigenomix Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Xcode Life
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio